Florida’s Recent Heat Protection Preemption Law Could Disproportionately Affect Hispanic and Noncitizen Immigrant Workers April 26, 2024 Issue Brief The Florida legislation prevents city and county governments from requiring that employers, including government contractors, provide heat protections for outdoor workers outside of those required under state or federal law. These protections include requiring water breaks and other cooling measures for outdoor workers. The law could impact nearly 1.8 million nonelderly adult outdoor workers in Florida, who are disproportionately Hispanic and noncitizen immigrant workers.
April 25, 2024 Page From Drew Altman Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the…
Forward or Backward on the Uninsured? April 25, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman looks back at the remarkable progress made in expanding coverage for the uninsured and what it could mean politically for today’s remaining uninsured—a population that has had little clout historically and will command even less attention now.
Donor Government Funding for Global Family Planning Declines to Lowest Level Since 2016 April 24, 2024 News Release A new KFF analysis finds donor government funding for family planning efforts in low- and middle-income countries totaled US$1.35 billion in 2022, a decline of 9% (US$129 million) compared to 2021 ($1.48 billion). This figure marks the lowest level of funding since 2016 ($1.31 billion). While some of the decline…
An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk April 24, 2024 News Release In a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of Wegovy (semaglutide) now that the Food and Drug Administration has approved the use of the anti-obesity drug to reduce the risk of heart attacks and stroke in certain patients. This change potentially…
What are the Implications of the Dobbs Ruling for Racial Disparities? April 24, 2024 Issue Brief This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
Donor Government Funding for Family Planning in 2022 April 24, 2024 Report This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2022, which totaled US$1.35 billion and was a decline of 9% (US$129 million) compared to the 2021 amount (US$1.48 billion). While the decline was due to decreases in funding by most donor governments, a significant share can be attributed to exchange rate fluctuations resulting from the rise in value of the U.S. dollar against most currencies during 2022.
A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity April 24, 2024 Issue Brief The FDA recently approved a new use for Wegovy, the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese – a decision that opens the door to Medicare coverage of Wegovy, which is prohibited by law from covering drugs used for obesity. This brief analyses how many Medicare beneficiaries could be eligible for the new use of Wegovy and the potential impact on Medicare spending.